<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Gemcitabine direnci &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/gemcitabine-direnci/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 02:59:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Gemcitabine direnci &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Glutamine Boosts Gemcitabine Resistance in Pancreatic Cancer</title>
		<link>https://bioengineer.org/glutamine-boosts-gemcitabine-resistance-in-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 02:58:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[**5 uygun etiket:** Pankreas kanseri]]></category>
		<category><![CDATA[Gemcitabine direnci]]></category>
		<category><![CDATA[Gemcitabine resistance]]></category>
		<category><![CDATA[Glutamin metabolizması]]></category>
		<category><![CDATA[Glutamine Metabolism]]></category>
		<category><![CDATA[İmmün kaçış **Açıklama:** 1. **Pankreas kanseri:** Çalışmanın temel odağı pankreas kanseri olduğu için en temel etikettir. 2. **Gemcitabine direnci:** Mak]]></category>
		<category><![CDATA[immune evasion]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[SLC6A14]]></category>
		<guid isPermaLink="false">https://bioengineer.org/glutamine-boosts-gemcitabine-resistance-in-pancreatic-cancer/</guid>

					<description><![CDATA[In an increasingly cancer-conscious world, new research findings are pointing towards a promising therapeutic strategy to tackle one of the most aggressive forms of cancer: pancreatic cancer. A collaborative study led by Kang et al. has provided groundbreaking insights into the biochemical pathways that underlie the resistance of pancreatic cancer cells to gemcitabine, a commonly [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319612</post-id>	</item>
	</channel>
</rss>
